Dyne Therapeutics, Inc. - COM (DYN)

Q2 2017 13F Holders as of 6/30/2017

Type / Class
Equity / COM
Number of holders
156
Total Shares
147M
Shares change
-1.91M
Total reported value, excl. options
$1.22B
Value change
-$11.6M
Put/Call ratio
0.2
Number of buys
90
Number of sells
-88
Price
$8.27
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.